Skip to main content

Purpose & Achievements

Improving Health & Medicine

Research at the Weizmann Institute of Science has led to improved health and better medicine for people everywhere.

Weizmann scientists discovered the basis of amniocentesis and new fertility treatments; discovered Copaxone® and Rebif®, today two of the frontline treatments for multiple sclerosis (MS); and developed a technology used in advanced medical imaging scans.

They are creating diabetes vaccines and flu vaccines; using stem cells to grow new organs and T cells to treat damaged spines; and studying the origins of life and the origins of disease. Institute scientists are also advancing into the future of medicine: at its new Nancy and Stephen Grand Israel National Center for Personalized Medicine, treatments and therapies designed for the individual patient will become a reality.

From understanding the origins of disease to developing the basis for new medicines, the Institute’s basic science research is leading to a healthier world.

Weizmann by the Numbers

  • Weizmann research led to two
    of the first-line drugs for treating multiple sclerosis (MS):
    Copaxone® and Rebif®

  • Chances of pregnancy double after our biopsy-based fertility treatment

  • Prof. Ada Yonath: first woman in 45 years – just the fourth in history – to win the Nobel in Chemistry, and the first Israeli female laureate



    Why Do Cancer Patients Lose So Much Weight?

    Wasting syndrome – a deadly cancer side-effect – might be diagnosed and treated early on, according to a new study

    Down with MS

    Focusing on the ups and downs of multiple sclerosis, Weizmann Institute researchers discover a major player in its remission

    Plant Research Reaches a New High

    Weizmann scientists revealed the step-by-step production of cannabinoids in a South African plant, pointing to new ways of manufacturing them for medical use

    Decades-Old Mystery of Red Blood Cell Production Finally Solved

    Identifying the cells producing the hormone EPO may lead to the development of new therapies for treating anemia resulting from kidney disease and other conditions

    Putting gene expression in its place

    Prof. Nir Yosef is combining single-cell genomic sequencing with a powerful partner: artificial intelligence

    Inside the mind of mitochondria

    Dr. Tslil Ast is looking for therapeutic targets in devastating diseases